8月18日，湖岸生物(LSB)盘中上涨3.36%，截至22:40，报0.806美元/股，成交2.55万美元，总市值3322.57万美元。
财务数据显示，截至2025年03月31日，湖岸生物收入总额6.15亿人民币，同比增长7.24%；归母净利润-9998.25万人民币，同比增长76.93%。
资料显示，湖岸生物技术有限公司是一家在开曼群岛注册成立的境外控股母公司,主要由其境内实体子公司北京依生生物技术有限公司运营。依生生物技术有限公司是一家全球性的生物制药公司,致力于发现、开发、生产和商业化新一代疫苗和治疗性生物制剂,用于治疗传染病和癌症。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.